Company Search:
Advanced Search
Sponsored Links
Adamas Pharmaceuticals Inc Company Snapshot
Adamas Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adamas Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Aquestive Therapeutics Inc (2019 sales of $52.61 million ), Alimera Sciences, Incorporation ($53.94 million of which 100% was Medical Marketing), and Pliant Therapeutics Inc ($57.05 million of which 100% was PHARMACEUTICAL).

Sales Analysis. Adamas Pharmaceuticals Inc reported sales of $54.64 million for the year ending December of 2019. This represents an increase of 60.5% versus 2018, when the company's sales were $34.05 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, Adamas Pharmaceuticals Inc had sales of $55.85 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Adamas Pharmaceuticals Inc
  Stock Performance Chart for Adamas Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 4.44
(Figures in U.S. Dollars)
1 Week -7.9%   13 Weeks -6.7%  
4 Weeks 66.3%   52 Weeks 11.6%  
Adamas Pharmaceuticals Inc Key Data:
  Ticker: ADMS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 54,637,000
(Year Ending Jan 2020).
Employees: 136
  Currency: U.S. Dollars Market Cap: 125,571,370
  Fiscal Yr Ends: December Shares Outstanding: 28,281,840
  Share Type: Ordinary Closely Held Shares: 771,973
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.